Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $27,643 | 1,519 | 99.6% |
| Education | $122.31 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,672 | 121 | $0 (2024) |
| Novo Nordisk Inc | $2,844 | 177 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,438 | 126 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,325 | 113 | $0 (2024) |
| ABBVIE INC. | $2,298 | 113 | $0 (2024) |
| Lilly USA, LLC | $1,993 | 137 | $0 (2024) |
| Amgen Inc. | $1,889 | 81 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,358 | 65 | $0 (2023) |
| Astellas Pharma US Inc | $1,093 | 66 | $0 (2023) |
| PFIZER INC. | $930.91 | 95 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,147 | 180 | AstraZeneca Pharmaceuticals LP ($992.92) |
| 2023 | $3,793 | 189 | GlaxoSmithKline, LLC. ($550.52) |
| 2022 | $3,548 | 178 | ABBVIE INC. ($828.38) |
| 2021 | $4,847 | 251 | AstraZeneca Pharmaceuticals LP ($652.22) |
| 2020 | $3,358 | 193 | Allergan, Inc. ($470.69) |
| 2019 | $2,909 | 183 | Novo Nordisk Inc ($397.59) |
| 2018 | $2,224 | 154 | Novo Nordisk Inc ($314.16) |
| 2017 | $2,938 | 196 | SANOFI-AVENTIS U.S. LLC ($397.31) |
All Payment Transactions
1,524 individual payment records from CMS Open Payments — Page 1 of 61
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Inflammation | ||||||
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $2.93 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Diabetes Care | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.53 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.26 | General |
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $86.28 | General |
| Category: Cardiovascular | ||||||
| 11/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: PAIN | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: PSYCHIATRY | ||||||
| 11/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: UROLOGY | ||||||
| 10/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,540 | 2,349 | $304,155 | $130,429 |
| 2022 | 16 | 1,489 | 2,422 | $323,163 | $138,400 |
| 2021 | 14 | 1,756 | 2,892 | $357,423 | $173,678 |
| 2020 | 15 | 1,723 | 2,808 | $320,634 | $130,512 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 348 | 780 | $156,000 | $62,194 | 39.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 201 | 201 | $40,200 | $24,850 | 61.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 198 | 403 | $52,390 | $23,128 | 44.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 31 | 31 | $6,200 | $4,902 | 79.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 213 | 213 | $9,585 | $3,749 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $11,400 | $3,730 | 32.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 243 | 385 | $10,010 | $3,176 | 31.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 73 | 73 | $4,015 | $2,154 | 53.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 73 | 73 | $7,300 | $1,555 | 21.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 37 | $4,440 | $341.11 | 7.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 46 | 72 | $1,080 | $245.52 | 22.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 13 | 13 | $845.00 | $211.44 | 25.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 16 | $480.00 | $161.70 | 33.7% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 14 | 14 | $210.00 | $31.41 | 15.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 374 | 965 | $193,000 | $78,058 | 40.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 199 | 199 | $39,800 | $25,237 | 63.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 173 | 324 | $42,120 | $18,261 | 43.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 26 | 26 | $5,200 | $4,228 | 81.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $11,100 | $3,958 | 35.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 78 | 78 | $4,290 | $2,225 | 51.9% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 72 | 72 | $4,320 | $2,098 | 48.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 95 | 95 | $3,075 | $1,562 | 50.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 274 | 426 | $11,076 | $1,233 | 11.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 27 | 36 | $2,340 | $427.80 | 18.3% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 12 | 12 | $876.00 | $329.81 | 37.6% |
About Dr. Karen Banks Lindner, DO
Dr. Karen Banks Lindner, DO is a Internal Medicine healthcare provider based in Norwich, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598798183.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karen Banks Lindner, DO has received a total of $27,765 in payments from pharmaceutical and medical device companies, with $4,147 received in 2024. These payments were reported across 1,524 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($27,643).
As a Medicare-enrolled provider, Banks Lindner has provided services to 6,508 Medicare beneficiaries, totaling 10,471 services with total Medicare billing of $573,019. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Norwich, NY
- Active Since 07/08/2006
- Last Updated 01/09/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598798183
Products in Payments
- JARDIANCE (Drug) $1,925
- TRELEGY ELLIPTA (Drug) $1,388
- FARXIGA (Drug) $1,341
- Ozempic (Drug) $1,183
- BREZTRI (Drug) $1,138
- UBRELVY (Drug) $1,136
- XARELTO (Drug) $941.47
- VRAYLAR (Drug) $882.53
- Otezla (Drug) $707.02
- TRULICITY (Drug) $596.10
- QULIPTA (Drug) $575.76
- Vascepa (Drug) $488.32
- EMGALITY (Drug) $448.27
- NURTEC ODT (Drug) $447.45
- Victoza (Drug) $435.33
- Rybelsus (Drug) $428.23
- CHANTIX (Drug) $423.07
- SPIRIVA RESPIMAT (Drug) $415.59
- Repatha (Biological) $412.50
- INVOKANA (Drug) $410.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Norwich
Dr. Paras Bhatt, Md, MD
Internal Medicine — Payments: $153,816
Dr. Paul Deutsch, Md, Rph, MD, RPH
Internal Medicine — Payments: $29,145
Dr. Salman Zafar, Md, MD
Internal Medicine — Payments: $20,019
Dr. Jie Yang, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $16,762
Priya Bakaya, Md, MD
Internal Medicine — Payments: $12,642
Dr. Terry Baksh, M.d, M.D
Internal Medicine — Payments: $11,690